Lanean...
Systematic population screening, using biomarkers and genetic testing, identifies 2.5% of the UK pediatric diabetes population with monogenic diabetes
OBJECTIVE: Monogenic diabetes is rare but an important diagnosis in pediatric diabetes clinics. These patients are often not identified as this relies on recognition of key clinical features by an alert clinician. Biomarkers (islet autoantibodies and C-peptide) can assist in exclusion of patients wi...
Gorde:
| Argitaratua izan da: | Diabetes Care |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5018394/ https://ncbi.nlm.nih.gov/pubmed/27271189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/dc16-0645 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|